A structural feature of N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulfonamide (NS-398) that governs its selectivity and affinity for cyclooxygenase 2 (COX2)
- 1 August 1995
- journal article
- Published by Springer Nature in Inflammation Research
- Vol. 44 (2), S145-S146
- https://doi.org/10.1007/bf01778304
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitroProstaglandins, 1994
- Review article: non‐steroidal, antiinflammatory drugs—the extending scope of gastrointestinal side effectsAlimentary Pharmacology & Therapeutics, 1992
- Mitogen‐inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugsDrug Development Research, 1992
- A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesiaPain, 1988
- Renal Syndromes Associated with Nonsteroidal Antiinflammatory DrugsNew England Journal of Medicine, 1984